Data / Form D filings / QUARK PHARMACEUTICALS INC
QUARK PHARMACEUTICALS INC: Form D filing
QUARK PHARMACEUTICALS INC, a pharmaceuticals company in Fremont, CA, filed a Form D with the SEC in 2010. The latest, on June 1, 2010, reports $10 million sold of a $10 million offering to 9 investors.
Find out what QUARK PHARMACEUTICALS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 6501 DUMBARTON CIRCLE, Fremont, CA, 94555
- Phone
- (510) 402-4020
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- California
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 920189
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 1, 2010 | New notice | $10,000,000 | $10,000,000 | $0 | 9 | May 17, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Juliana Friedmann, M.Sc. | Executive Officer | |
| Peter A. Thompson, M.D. | Director | |
| Trent M. Gunter | Director | |
| Elena Feinstein, Ph.D. | Executive Officer | |
| Shai Erlich, Ph.D. | Executive Officer | |
| Kazuyuki B. Matsui | Director | |
| Rami Skaliter | Executive Officer | |
| James D. Thompson, Ph.D. | Executive Officer | |
| Smadar Shakked | Executive Officer | |
| Daniel Zurr, Ph.D. | Executive Officer, Director | |
| Philip B. Simon | Director | |
| Toru B. Mio | Director | |
| Philip M. Hahn | Director | |
| Robert L. Jones | Executive Officer | |
| Carlos D. Benaim, M.Sc. | Executive Officer |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of May 31, 2010 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what QUARK PHARMACEUTICALS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.